Table 2.
Unadjusted Rates of Performance Measures by Site of Care
| Performance measures (%) | CHCs | Private practices | p Value |
|---|---|---|---|
| High-value care | |||
| Tobacco cessation counseling | 57.6 (46.7, 68.6) | 61.8 (52.7, 70.9) | 0.55 |
| Weight reduction counseling | 34.0 (28.3, 39.8) | 30.0 (26.7, 33.4) | 0.24 |
| Anticoagulant use in AFib | 68.7 (55.7, 81.8) | 59.3 (51.7, 66.9) | 0.25 |
| Aspirin use in CAD | 43.5 (31.9, 55.1) | 40.3 (34.6, 45.9) | 0.64 |
| BB use in CAD | 47.5 (37.7, 57.3) | 38.9 (32.6, 45.3) | 0.14 |
| Statin use in CAD | 46.9 (37.3, 56.5) | 44.9 (39.4, 50.5) | 0.75 |
| BB in CHF | 46.9 (31.9, 61.9) | 36.5 (30.6, 42.4) | 0.20 |
| ACEi/ARB in CHF | 44.1 (28.8, 59.3) | 31.6 (25.8, 37.4) | 0.13 |
| Antiplatelet use in CVD | 31.8 (17.6, 46.0) | 35.2 (28.9, 41.5) | 0.70 |
| Statin use in DM | 37.0 (31.9, 42.1) | 35.5 (32.6, 38.4) | 0.62 |
| Treatment for depression | 50.6 (46.1, 55.0) | 51.9 (49.5, 54.4) | 0.58 |
| Treatment for osteoporosis | 35.7 (27.0, 44.4) | 23.2 (18.8, 27.5) | 0.007 |
| Low-value care | |||
| No screening EKG in GME | 98.7 (97.4, 99.9) | 88.0 (84.2, 91.8) | < 0.001 |
| No screening CBC in GME | 75.9 (70.7, 81.0) | 65.7 (61.9, 69.6) | 0.003 |
| No screening UA in GME | 86.0 (81.5, 90.6) | 80.5 (76.7, 84.2) | 0.07 |
| Antibiotics for URI | 48.3 (40.9, 55.6) | 63.1 (58.2, 68.0) | < 0.001 |
| Opioids for back/neck pain | 38.8 (33.7, 43.9) | 36.4 (32.2, 40.7) | 0.48 |
| CT/MRI for back/neck pain | 4.9 (3.1, 6.7) | 5.2 (4.2, 7.0) | 0.53 |
| Opioids for headache | 17.3 (10.7, 23.9) | 13.2 (9.9, 16.5) | 0.26 |